ArticleJournal of medical case reports2025
A clinical presentation of rhino-orbito-cerebral mucormycosis in a patient with aplastic anemia: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAplastic anemia is a hematologic disorder characterized by bone marrow failure and profound neutropenia, which increases the risk of opportunistic infections such as mucormycosis, an aggressive fungal disease. This condition requires early diagnosis and integrated treatment strategies to reduce the high mortality rate. We report a rare case of rhino-orbito-cerebral mucormycosis in a patient with aplastic anemia. CASE PRESENTATION: A 16-year-old Middle Eastern (Persian, Iranian) male with a history of aplastic anemia presented with unilateral right-sided facial swelling. He was initially diagnosed with a bacterial soft tissue abscess and treated with antibiotics. Owing to a lack of response, further imaging and histopathological studies were performed, which revealed invasive mucormycosis. The patient received antifungal therapy, but surgical debridement was not performed because of severe thrombocytopenia. His condition deteriorated, and he was admitted to the intensive care unit. Despite resuscitation efforts, the patient died on day 17 of hospitalization.
conclusionThis case highlights the diagnostic and therapeutic challenges in managing mucormycosis in patients with hematological disorders. A key factor contributing to the unfavorable outcome was the prolonged interval between symptom onset and rhino-orbito-cerebral mucormycosis diagnosis. Physicians should consider invasive fungal infections in all immunocompromised patients, particularly those with aplastic anemia, when they present with facial soft tissue infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.